DK3901141T3 - Ny form af isoquinolin-sulfonamid - Google Patents

Ny form af isoquinolin-sulfonamid Download PDF

Info

Publication number
DK3901141T3
DK3901141T3 DK19899054.1T DK19899054T DK3901141T3 DK 3901141 T3 DK3901141 T3 DK 3901141T3 DK 19899054 T DK19899054 T DK 19899054T DK 3901141 T3 DK3901141 T3 DK 3901141T3
Authority
DK
Denmark
Prior art keywords
new form
isoquinoline sulfonamide
isoquinoline
sulfonamide
new
Prior art date
Application number
DK19899054.1T
Other languages
English (en)
Inventor
Hiroyoshi Hidaka
Kengo Sumi
Takashi Izuhara
Original Assignee
D Western Therapeutics Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D Western Therapeutics Inst Inc filed Critical D Western Therapeutics Inst Inc
Application granted granted Critical
Publication of DK3901141T3 publication Critical patent/DK3901141T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
DK19899054.1T 2018-12-17 2019-12-16 Ny form af isoquinolin-sulfonamid DK3901141T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018235213 2018-12-17
PCT/JP2019/049099 WO2020129876A1 (ja) 2018-12-17 2019-12-16 イソキノリンスルホンアミドの新規な形態

Publications (1)

Publication Number Publication Date
DK3901141T3 true DK3901141T3 (da) 2024-02-26

Family

ID=71101331

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19899054.1T DK3901141T3 (da) 2018-12-17 2019-12-16 Ny form af isoquinolin-sulfonamid

Country Status (15)

Country Link
US (1) US11427546B2 (da)
EP (1) EP3901141B1 (da)
JP (1) JP7425482B2 (da)
KR (1) KR20210104729A (da)
CN (1) CN113195453B (da)
AU (1) AU2019402422A1 (da)
BR (1) BR112021011739A2 (da)
CA (1) CA3120751A1 (da)
DK (1) DK3901141T3 (da)
EA (1) EA202191339A1 (da)
FI (1) FI3901141T3 (da)
MX (1) MX2021007233A (da)
PT (1) PT3901141T (da)
SG (1) SG11202105739YA (da)
WO (1) WO2020129876A1 (da)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1370914A (en) 1971-07-06 1974-10-16 Ici Ltd Paint compositions
DE3943678C2 (de) * 1988-12-26 1999-11-25 Hiroyoshi Hidaka Isochinolinsulfonsäureamide, Verfahren zu deren Herstellung und diese Amide enthaltende pharmazeutische Zusammensetzung
US5340811A (en) 1990-03-08 1994-08-23 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinoline-or quinoline-sulfonamide derivative and a pharmaceutical composition comprising the same
KR100236853B1 (ko) 1995-07-03 2000-02-01 야마모토 카즈모토 1-(5-이소퀴놀린술포닐)호모피페라진 염산염 수화물
JP2899953B2 (ja) 1995-07-03 1999-06-02 旭化成工業株式会社 1−(5−イソキノリンスルホニル)ホモピペラジン塩酸塩1/2水和物
MY139797A (en) 2004-11-29 2009-10-30 Kowa Co (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1, 4-homopiperazine hydrochloride dihydrate
ES2396795T3 (es) 2007-07-02 2013-02-27 Asahi Kasei Pharma Corporation Compuesto de sulfonamida y cirstal del mismo
BR112013015604B1 (pt) 2010-12-22 2021-11-03 D. Western Therapeutics Institute, Inc Derivado de isoquinolina-6-sulfonamida, composição farmacêutica compreendendo o mesmo e uso do dito composto para tratar ou prevenir glaucoma, hipertensão ocular ou doença cardiovascular
JP5819705B2 (ja) 2011-11-09 2015-11-24 興和株式会社 イソキノリン誘導体塩酸塩無水物結晶

Also Published As

Publication number Publication date
AU2019402422A1 (en) 2021-06-17
SG11202105739YA (en) 2021-07-29
JP7425482B2 (ja) 2024-01-31
US11427546B2 (en) 2022-08-30
CN113195453A (zh) 2021-07-30
EP3901141B1 (en) 2024-02-07
AU2019402422A8 (en) 2021-07-01
PT3901141T (pt) 2024-03-04
KR20210104729A (ko) 2021-08-25
EP3901141A1 (en) 2021-10-27
WO2020129876A1 (ja) 2020-06-25
BR112021011739A2 (pt) 2021-08-31
EA202191339A1 (ru) 2021-08-27
MX2021007233A (es) 2021-07-15
JPWO2020129876A1 (ja) 2021-11-04
CN113195453B (zh) 2024-04-30
EP3901141A4 (en) 2022-07-13
FI3901141T3 (fi) 2024-03-01
US20220017469A1 (en) 2022-01-20
CA3120751A1 (en) 2020-06-25

Similar Documents

Publication Publication Date Title
DK3512850T3 (da) Inhibitorer af menin-mll-interaktionen
MA50567A (fr) Nouveaux composés de sulfonamide carboxamide
DK3468966T3 (da) Inhibitorer af menin-mll-interaktionen
MA49901A (fr) Nouveaux composés de sulfonamide carboxamide
MA49904A (fr) Nouveaux composés de sulfonamide carboxamide
MA56075A (fr) Nouveaux composés de sulfonamide carboxamide
CL2019002503A1 (es) Compuesto de sulfamida cíclico y métodos de uso de los mismo.
DK3515296T3 (da) Måling af vævslevedygtighed
DK3554240T3 (da) Kombinationer af aktive forbindelser
DK3452448T3 (da) Modulatorer af den integrerede stressvej
DK3558024T3 (da) Fremstilling af beta-lactoglobulinpræparater
DK3749181T3 (da) Detektering af vævsbeskadigelse
DK3433234T3 (da) Allosteriske modulatorer af nicotinacetylcholinreceptorer
DK3509581T3 (da) Formuleringer af (r)-2-amino-3-phenylpropylcarbamat
DK3668851T3 (da) Fremgangsmåde til fremstilling af thiocarbonater
DK3457851T3 (da) Derivater af sobetirom
DK3891145T3 (da) Modulatorer af trex1
DK3072952T3 (da) Anvendelse af en ny køleolie
DK3833662T3 (da) Inhibitorer af protein-protein-interaktionen mellem KEAP-1-NRF2-
DK3328395T3 (da) Ny brug af dextransulfat
DK3649781T3 (da) Forbedring af tvungen grænseopdeling
DK3927899T3 (da) Nedvibrering af funderinger
DK3737677T3 (da) Tetrahydroisoquinolinforbindelser
DK3433354T3 (da) Generering af syntetiske genomer
DK3738330T3 (da) Håndtering af identifikatorvalidering